Acrivon Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $75k | 63k | 1.19 |
| 2024-12-31 | $209k | 35k | 6.02 |
| 2024-09-30 | $251k | 36k | 7.00 |
| 2024-06-30 | $100k | 17k | 5.80 |
| 2024-03-31 | $123k | 17k | 7.15 |
| 2023-12-31 | $126k | 26k | 4.92 |
| 2023-09-30 | $47k | 4.9k | 9.56 |
| 2023-06-30 | $110k | 8.5k | 12.96 |
| 2022-12-31 | $10k | 869 | 11.52 |